Abstract
Mast cells, the major source of tissue heparin, line the vascular system. On stimulation, rat serosal mast cells release soluble heparin proteoglycans (HEP-PGs) of very high molecular weight (7500(K)). We compared the effects of HEP-PGs and standard heparins (average molecular weights, 15,000 and 5,000) on platelet-collagen interactions in vitro. In contrast with the standard heparins, HEP-PGs completely inhibited collagen-induced platelet aggregation and serotonin release in platelet-rich plasma. The inhibition caused by HEP-PGs depended on its macromolecular structure. In flowing blood, HEP-PGs also inhibited platelet deposition on a collagen-coated surface both at low and high shear rates. Although HEP-PGs did not block glycoprotein (GP) Ia/IIa-mediated platelet adhesion, they attenuated subsequent platelet activation and aggregation, as well as fibrinogen binding to platelets after collagen stimulation. HEP-PGs did not bind to platelets but bound tightly to von Willebrand factor (vWf) and enhanced its binding to collagen. Although platelet adhesion at high shear rate and vWf binding to GP Ib after ristocetin stimulation were not markedly affected, HEP-PGs reduced thrombin-induced aggregation and vWf binding to GP IIb/IIIa. ...Continue Reading
References
Aug 1, 1978·Thrombosis Research·M L LarsenK Gjesdal
Jan 1, 1992·Vox Sanguinis·M Burnouf-Radosevich, T Burnouf
Sep 1, 1991·Blood Reviews·E M BeversR F Zwaal
Jun 20, 1991·The New England Journal of Medicine·B S Bochner, L M Lichtenstein
Mar 14, 1991·European Journal of Biochemistry·J J SixmaH Pannekoek
May 1, 1991·The Journal of Clinical Investigation·M SobelD Marques
Jun 1, 1991·Journal of the American College of Cardiology·F D KolodgieJ Smialek
Jan 1, 1989·Annals of the New York Academy of Sciences·H L MessmoreJ Seghatchian
Sep 1, 1989·British Journal of Haematology·A S LawrieG F Savidge
Jan 1, 1989·Methods in Enzymology·H Holmsen, C A Dangelmaier
Jan 1, 1989·Methods in Enzymology·K S SakariassenH R Baumgartner
Jan 1, 1989·Methods in Enzymology·S Timmons, J Hawiger
Dec 5, 1985·Nature·H K NieuwenhuisJ J Sixma
Feb 1, 1987·The Journal of Clinical Investigation·K K Hamilton, P J Sims
Sep 12, 1986·Cell·S A Santoro
Aug 15, 1986·Thrombosis Research·F FernandezM R Buchanan
Jul 1, 1973·The Biochemical Journal·A E Bolton, W M Hunter
Jul 1, 1983·The Journal of Clinical Investigation·B S CollerC A Sullivan
Jan 1, 1982·Methods in Enzymology·E J Miller, R K Rhodes
May 1, 1994·The Biochemical Journal·L F MortonM J Barnes
Jan 1, 1995·Seminars in Thrombosis and Hemostasis·B Kehrel
Jan 28, 1993·The New England Journal of Medicine·S J Galli
Citations
Jul 12, 2002·Journal of Cellular Biochemistry·Selim ElhadjKimberly Forsten-Williams
Dec 20, 2000·Fertility and Sterility·M SakataT Kojima
Jan 5, 2002·Thrombosis Research·P MustonenR Lassila
Mar 18, 2000·Journal of Ethnopharmacology·A T Atanasov, V Spasov
Jul 25, 2000·Molecular Medicine Today·J L KelleyG Krishnaswamy
Aug 12, 1999·British Journal of Haematology·C GardinerS J Machin
Jul 14, 2016·Clinical and Experimental Nephrology·Raimo TuuminenRiitta Lassila
Jun 15, 2006·Izvestiia Akademii nauk. Seriia biologicheskaia·L A LiapinaT Iu Obergan
May 15, 2007·Immunological Reviews·Petri T Kovanen
Sep 1, 2007·Journal of Cellular and Molecular Medicine·Ken A LindstedtPetri T Kovanen
Oct 9, 2015·Medicine·Ana B CarvalhosaMarie-Olivia Chandesris
Nov 19, 2010·Allergy·T TakedaM Shima
Sep 14, 2019·International Journal of Molecular Sciences·Petri T Kovanen
Aug 23, 2019·ELife·Timo VögtleYotis A Senis
Feb 28, 2021·American Journal of Hematology·Chrysovalantou ChatzidimitriouTheodoros P Vassilakopoulos
Jun 17, 2021·Journal of Cardiovascular Pharmacology·Simon CraigeRiitta Lassila
Nov 14, 2021·Analytical and Bioanalytical Chemistry·Maximilian WinzelyGernot Friedbacher